. Cdk5 as a drug target for the treatment of Alzheimer's disease. J Mol Neurosci. 2002 Dec;19(3):267-73. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments